Brooks O'Neil

Chris Kallos

Joshua Jennings

Ross Osborn

Ryan Zimmerman

Eric Anderson

John Hester

Josh Jennings

Lyanne Harrison

Matthew Park

Phillip Dantoin

Samantha

- AVITA Medical, Inc. (RCEL) has received the **CE Mark** under the European Union Medical Device Regulation (EU MDR) for **RECELL GO**, which permits its commercialization in Europe and other markets that recognize the CE Mark.  **[1762303_76099baff79147368bf3d488c729aa9c_0]** 
- RECELL GO is a point-of-care device used by healthcare professionals to prepare a suspension of a patient’s own skin cells (Spray-On Skin™ Cells) to promote healing in burns and traumatic or surgical wounds.  **[1762303_76099baff79147368bf3d488c729aa9c_0]** 
- Data presented at the 2025 European Burns Association Congress demonstrated that adults with deep partial-thickness burns treated with RECELL experienced a **36% reduction in hospital stays** compared with traditional grafting.  **[1762303_76099baff79147368bf3d488c729aa9c_0]** 
- AVITA Medical will begin commercialization of RECELL GO in select European countries, including **Germany, Italy, and the United Kingdom**.  **[1762303_76099baff79147368bf3d488c729aa9c_0]**

AVITA Medical Receives CE Mark for RECELL GO, Enabling European Commercialization

AVITA Medical (RCEL)